CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 13 enrolled
Drug / intervention
Cosyntropin administrationdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01764711
NCT01764711N/ACompleted
CompareCT.gov

Aldosterone and Sodium Regulation in Postural Tachycardia Syndrome Aim 1b: ACTH Stimulation

Vanderbilt University·interventional·Posted Jan 9, 2013·Updated Mar 31, 2022

In Brief

A clinical study evaluating Cosyntropin administration for Postural Tachycardia Syndrome. Completed, enrolled 13 participants across 1 site.

Detailed Summary

This study is to determine different chemical levels in the blood during a low salt diet. This study will compare normal volunteers to those with Postural Tachycardia Syndrome (POTS)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostural Tachycardia Syndrome
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 9, 2013
Enrollment StartJan 1, 2013
Primary CompletionDec 31, 2020
TodayJul 2, 2026
Enrollment to primary: 8 yearsPosted 13.5 years ago

Interventions

Cosyntropin administrationdrug

After 30 minutes of rest in the seated position, participants will be given cosyntropin intravenously. Blood samples will be taken 30 minutes pre-drug administration, 30 minutes post and 60 minutes post drug administration.